Article Details

Ionis plans NDA filing after hereditary angioedema trial meets primary endpoint

Retrieved on: 2024-01-23 17:26:08

Tags for this article:

Click the tags to see associated articles and topics

Ionis plans NDA filing after hereditary angioedema trial meets primary endpoint. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. Related ... According to GlobalData's Pharma Intelligence Center, donidalorsen is forecast to ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up